Bausch Health Companies (BHC) Change in Inventory (2009 - 2026)
Bausch Health Companies (BHC) reported Change in Inventory of $14.0 million for Q1 2026, down 53.33% on a YoY basis from $30.0 million in Q1 2025, and up 180.0% sequentially from $5.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Change in Inventory data on file, last reported at $14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 53.33% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (down 102.61% YoY), and the FY2025 full-year result was $12.0 million, down 95.51% from the prior year.
- Change in Inventory improved to $14.0 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $144.0 million in Q1 2024 to a low of -$16.0 million in Q3 2025.
- A 5-year average of $47.8 million and a median of $42.0 million in 2024 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory jumped 2400.0% in 2023 and slumped 138.1% in 2025, its largest moves.
- Tracing BHC's Change in Inventory over 5 years: stood at $4.0 million in 2022, then jumped by 2400.0% to $100.0 million in 2023, then sank by 51.0% to $49.0 million in 2024, then slumped by 89.8% to $5.0 million in 2025, then jumped by 180.0% to $14.0 million in 2026.
- Business Quant data shows BHC's Change in Inventory at $14.0 million in Q1 2026, $5.0 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |